UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
AMENDMENT NO. 1
(Mark One)
[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED: March 31, 1996
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM ___________TO_________
Commission file number: 0-22740
FINANCING FOR SCIENCE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 06-1179144
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
10 WATERSIDE DRIVE
FARMINGTON, CONNECTICUT 06032-3065 06032-3065
(Address of principal executive offices) (Zip Code)
(860) 676-1818
(Registrant's telephone number, including area code)
NOT APPLICABLE.
(Former name, former address and former fiscal year, if changed since last
report)
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days.
Yes [ X ] No [ ]
APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date: 5,394,600 shares as of
April 26, 1996.
<PAGE>
Item 3. Exhibits.
EXHIBIT NO. The following exhibits are filed herewith
3.1 Restated Certificate of Incorporation of the Company incorporated
by reference to Exhibit 3.1 to the Company's Report on Form 10-Q for
the period ended June 30, 1994.
3.2 By-Laws of the Company incorporated by reference to Exhibit 3.2
to the Company's Report on Form 10-Q for the period ended
June 30, 1994.
4.1 Amended and Restated Indenture dated as of March 1, 1996 by and
between the Company, FSI Funding Corp. II and Manufacturers and
Traders Trust Company, Trustee, incorporated by reference to
Exhibit 4.1 to the Company's Report on Form 10-Q for the period
ended March 31, 1996.
4.2 Series 1996-1 Supplemental Indenture dated as of March 28, 1996
to the Amended and Restated Indenture by and between the Company,
FSI Funding Corp. II and Manufacturers and Traders Trust Company,
Trustee, dated as of March 1, 1996, incorporated by reference to
Exhibit 4.2 to the Company's Report on Form 10-Q for the period
ended March 31, 1996.
10.1 Amendment Agreement No. 1 dated as of March 1, 1996 to the
Contribution, Sale and Assignment Agreement by and between the
Company and FSI Funding Corp. II, dated as of March 1, 1995,
incorporated by reference to Exhibit 10.1 to the Company's Report
on Form 10-Q for the period ended March 31, 1996.
10.2 Sale Agreement Supplement dated as of March 28, 1996 to the
Contribution, Sale and Assignment Agreement by and between the
Company and FSI Funding Corp. II, dated as of March 1, 1995,
incorporated by reference to Exhibit 10.2 to the Company's Report
on Form 10-Q for the period ended March 31, 1996.
11 Statement re: Computation of Per Share Earnings.
(b) Reports on Form 8-K. The Registrant did not file any reports on
Form 8-K during the quarter ended March 31, 1996.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
FINANCING FOR SCIENCE INTERNATIONAL,INC.
ROBERT W. MAXWELL
Date: May 8, 1996
Robert W. Maxwell
President and Chief Operating Officer as
signatory on behalf of the Registrant
and as Chief Financial and Accounting
Officer
EXHIBIT 11
FINANCING FOR SCIENCE INTERNATIONAL, INC.
COMPUTATION OF EARNINGS PER SHARE
For the three months ended March 31, 1996
(Amounts in thousands, except per share amounts)
[S] [C]
Net earnings $ 764
=======
Weighted average number of shares outstanding 5,423
Weighted average shares issuable on exercise of
dilutive stock options 269
Weighted average shares of treasury stock (38)
-------
Weighted average number of common and
common equivalent shares 5,654
=======
Net earnings per share $ .14
=======
